Pharmaceutical-grade compounds with mass-spec validation, sealed chain-of-custody, and the documentation your protocol requires. No theatre. Just clean reagents and clear paperwork.
Lot · EV-024-REach compound is synthesized in our U.S. facility, validated against reference standards, and released only with a signed COA.
In stockTirzepatide is a synthetic dual agonist targeting the GLP-1 and GIP receptors. Research has focused on its metabolic effects, including glucose regulation and body-weight modulation. For research use only.
In stockTesamorelin is a synthetic analogue of Growth Hormone-Releasing Hormone (GHRH). Research has focused on its ability to stimulate endogenous growth hormone secretion and its potential effects on body composition. For research use only.
In stockTB-500 is a synthetic peptide derived from Thymosin Beta-4, a protein found in virtually all human and animal cells. Researchers study its potential role in tissue repair, wound healing, and cellular migration. For research use only.
In stockSermorelin is a synthetic analogue of Growth Hormone-Releasing Hormone (GHRH). Research has focused on its ability to stimulate endogenous growth hormone secretion. For research use only.
In stockSemax is a synthetic peptide derived from the adrenocorticotropic hormone (ACTH). Research has focused on its neuroprotective properties and potential role in cognitive enhancement, neurogenesis, and protection against ischemic injury. For research use only.
In stockSemaglutide is a synthetic GLP-1 receptor agonist. Research has focused on its effects on glucose homeostasis, insulin secretion, and appetite regulation. For research use only.
Every vial leaves the lab with a documented chain of custody. No batch ships without independent verification.
Compounds are produced in our DEA-licensed U.S. facility using Fmoc-SPPS on a controlled resin. No outsourcing, no overseas intermediates.
Each lot is run on reverse-phase HPLC against a reference standard and confirmed by ESI-MS. Endotoxin and residual solvent are quantified.
Lots are lyophilized, sealed under argon, and shipped with a numbered, institution-addressed certificate of analysis. Cold-chain monitored.
A triple-incretin investigational peptide. Eli Lilly’s LY3437943 synthesized to research grade, lyophilized, sealed under argon, and released with a full chromatographic trace.
Public release log of the last six lots. Each row links to the signed certificate of analysis, with HPLC and mass-spec traces attached.